{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:17:53Z","timestamp":1785320273608,"version":"3.55.0"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T00:00:00Z","timestamp":1386201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA12115-S1"],"award-info":[{"award-number":["R01CA12115-S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:title>Learning Objectives<\/jats:title>\n               <jats:p>Describe the impact of hypothyroidism in patients with cancer. Identify options for managing hypothyroidism in patients with cancer.<\/jats:p>","DOI":"10.1634\/theoncologist.2013-0237","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T02:35:00Z","timestamp":1386297300000},"page":"34-43","source":"Crossref","is-referenced-by-count":35,"title":["Hypothyroidism After a Cancer Diagnosis: Etiology, Diagnosis, Complications, and Management"],"prefix":"10.1093","volume":"19","author":[{"given":"Yvette","family":"Carter","sequence":"first","affiliation":[{"name":"Section of Endocrine Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Sippel","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,5]]},"reference":[{"key":"2021122308455024900_B1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","article-title":"Hypothyroidism","volume":"363","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"2021122308455024900_B2","first-page":"219","article-title":"Zur Kenntnis der lymphomatosen Veranderung der Schilddruse (struma lymphomatosa)","volume":"91","author":"Hashimoto","year":"1912","journal-title":"Archiv fur Klinische Chirurgie"},{"key":"2021122308455024900_B3","first-page":"820","article-title":"Auto-antibodies in Hashimoto's disease (lymphadenoid goitre)","volume":"271","author":"Campbell","year":"1956","journal-title":"Lancet"},{"key":"2021122308455024900_B4","first-page":"548","article-title":"Reminiscences on the isolation of thyroxine","volume":"39","author":"Kendall","year":"1964","journal-title":"Mayo Clin Proc"},{"key":"2021122308455024900_B5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/bj0210169","article-title":"Chemistry of thyroxine: Constitution and synthesis of thyroxine","volume":"21","author":"Harington","year":"1927","journal-title":"Biochem J"},{"key":"2021122308455024900_B6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(52)91952-1","article-title":"The identification of 3:5:3\u2032-L-triiodothyronine in human plasma","volume":"1","author":"Gross","year":"1952","journal-title":"Lancet"},{"key":"2021122308455024900_B7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI106304","article-title":"Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects","volume":"49","author":"Braverman","year":"1970","journal-title":"J Clin Invest"},{"key":"2021122308455024900_B8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-74-4-471","article-title":"Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function","volume":"74","author":"Mayberry","year":"1971","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: The Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122308455024900_B10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/jcem-45-1-45","article-title":"Abnormalities in thyroid function in relatives of patients with Graves\u2019 disease and Hashimoto's thyroiditis: Lack of correlation with inheritance of HLA-B8","volume":"45","author":"Chopra","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1210\/jcem-51-5-1123","article-title":"Changes in thyroid function in euthyroid subjects with a family history of Graves\u2019 disease: a follow-up study of 69 patients","volume":"51","author":"Tamai","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/edrv.22.5.0441","article-title":"Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: Recent insights and consequences for antenatal and postnatal care","volume":"22","author":"Muller","year":"2001","journal-title":"Endocr Rev"},{"key":"2021122308455024900_B14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-3476(05)80288-4","article-title":"Thyroid function after treatment of brain tumors in children","volume":"119","author":"Ogilvy-Stuart","year":"1991","journal-title":"J Pediatr"},{"key":"2021122308455024900_B15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jc.2002-020380","article-title":"A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B16","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-145-9-200611070-00008","article-title":"Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors","volume":"145","author":"Desai","year":"2006","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B18","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1210\/jc.2007-0586","article-title":"A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake","volume":"92","author":"Mannavola","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"2021122308455024900_B20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199607113350206","article-title":"Chronic autoimmune thyroiditis","volume":"335","author":"Dayan","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/1050725041517057","article-title":"Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?","volume":"14","author":"McLachlan","year":"2004","journal-title":"Thyroid"},{"key":"2021122308455024900_B22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem-70-3-742","article-title":"Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase","volume":"70","author":"Phillips","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1010072605757","article-title":"Resistance to thyroid hormone","volume":"1","author":"Weiss","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"2021122308455024900_B24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0046-8177(74)80063-8","article-title":"The fibrous variant of Hashimoto's thyroiditis","volume":"5","author":"Katz","year":"1974","journal-title":"Hum Pathol"},{"key":"2021122308455024900_B25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-104-3-355","article-title":"Hashimoto's thyroiditis. An uncommon cause of painful thyroid unresponsive to corticosteroid therapy","volume":"104","author":"Zimmerman","year":"1986","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-198109000-00003","article-title":"Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes","volume":"60","author":"Neufeld","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"2021122308455024900_B27","doi-asserted-by":"crossref","first-page":"548796","DOI":"10.1100\/2012\/548796","article-title":"Thyroid function after subtotal thyroidectomy in patients with Graves\u2019 hyperthyroidism","volume":"2012","author":"Limonard","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"2021122308455024900_B28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jpeds.2012.10.018","article-title":"Delayed diagnosis of hypothyroidism following excision of a thyroglossal duct cyst","volume":"162","author":"Lilley","year":"2013","journal-title":"J Pediatr"},{"key":"2021122308455024900_B29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0001-2998(71)81039-5","article-title":"Complications of radioiodine treatment of hyperthyroidism","volume":"1","author":"Becker","year":"1971","journal-title":"Semin Nucl Med"},{"key":"2021122308455024900_B30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1289\/ehp.99107303","article-title":"Juvenile hypothyroidism among two populations exposed to radioiodine","volume":"107","author":"Goldsmith","year":"1999","journal-title":"Environ Health Perspect"},{"key":"2021122308455024900_B31","first-page":"115","article-title":"Current status of radioimmunoglobulins in the treatment of human malignancy","volume":"3","author":"Order","year":"1989","journal-title":"Oncology (Williston Park)"},{"key":"2021122308455024900_B32","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1001\/archinte.1983.00350100052015","article-title":"Thyroid disease in hemochromatosis. Increased incidence in homozygous men","volume":"143","author":"Edwards","year":"1983","journal-title":"Arch Intern Med"},{"key":"2021122308455024900_B33","first-page":"340","article-title":"Amiodarone and the thyroid: A 2012 update","volume":"35","author":"Bogazzi","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2021122308455024900_B34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/endo-46-1-72","article-title":"Histopathological changes induced in the normal thyroid and other tissues of the rat by internal radiation with various doses of radioactive iodine","volume":"46","author":"Goldberg","year":"1950","journal-title":"Endocrinology"},{"key":"2021122308455024900_B35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0360-3016(95)02079-9","article-title":"A prospective analysis of subacute thyroid dysfunction after neck irradiation","volume":"34","author":"Nishiyama","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122308455024900_B36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0167-8140(92)90192-W","article-title":"Hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors","volume":"25","author":"Grande","year":"1992","journal-title":"Radiother Oncol"},{"key":"2021122308455024900_B37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin's disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/JPEM.2008.21.10.943","article-title":"Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy","volume":"21","author":"Bonato","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021122308455024900_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2011.03.002","article-title":"Radiation-induced hypothyroidism in head and neck cancer patients: A systematic review","volume":"99","author":"Boomsma","year":"2011","journal-title":"Radiother Oncol"},{"key":"2021122308455024900_B40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.coc.0000145985.64640.ac","article-title":"Thyroid function should be monitored following radiotherapy to the low neck","volume":"28","author":"Garcia-Serra","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"2021122308455024900_B41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.coc.0000217831.23820.85","article-title":"Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy","volume":"29","author":"Norris","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"2021122308455024900_B42","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20011201)92:11<2892::AID-CNCR10134>3.0.CO;2-T","article-title":"Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma","volume":"92","author":"Mercado","year":"2001","journal-title":"Cancer"},{"key":"2021122308455024900_B43","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1200\/JCO.2006.05.6879","article-title":"Survival and late effects in children with Hodgkin's lymphoma treated with MOPP\/ABV and low-dose, extended-field irradiation","volume":"24","author":"Chow","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B44","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1200\/JCO.2005.05.0195","article-title":"White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma","volume":"24","author":"Metzger","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/CMR.0b013e328358b373","article-title":"A pilot study of sunitinib malate in patients with metastatic uveal melanoma","volume":"22","author":"Mahipal","year":"2012","journal-title":"Melanoma Res"},{"key":"2021122308455024900_B46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2407-12-107","article-title":"The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure\u2014one institution study","volume":"12","author":"Rutkowski","year":"2012","journal-title":"BMC Cancer"},{"key":"2021122308455024900_B47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1179\/1973947812Y.0000000022","article-title":"Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer","volume":"24","author":"Del Fabbro","year":"2012","journal-title":"J Chemother"},{"key":"2021122308455024900_B48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ejca.2012.01.036","article-title":"Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study","volume":"48","author":"Feldt","year":"2012","journal-title":"Eur J Cancer"},{"key":"2021122308455024900_B49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"2021122308455024900_B50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.bjc.6605552","article-title":"Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: Final results and geographical analysis","volume":"102","author":"Cella","year":"2010","journal-title":"Br J Cancer"},{"key":"2021122308455024900_B51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.bjc.6604497","article-title":"The clinical implications of sunitinib-induced hypothyroidism: A prospective evaluation","volume":"99","author":"Wolter","year":"2008","journal-title":"Br J Cancer"},{"key":"2021122308455024900_B52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clpt.2005.06.010","article-title":"Imatinib induces hypothyroidism in patients receiving levothyroxine","volume":"78","author":"Groot","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"2021122308455024900_B53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2009.22.9427","article-title":"Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study","volume":"28","author":"Goss","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B54","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/thy.2010.0251","article-title":"Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia","volume":"20","author":"Kim","year":"2010","journal-title":"Thyroid"},{"key":"2021122308455024900_B55","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2001.19.15.3477","article-title":"Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma","volume":"19","author":"Phan","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.1999.17.2.529","article-title":"Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer","volume":"17","author":"Franzke","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B57","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.1993.11.7.1376","article-title":"Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment","volume":"11","author":"Weijl","year":"1993","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B58","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198806163182401","article-title":"Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells","volume":"318","author":"Atkins","year":"1988","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B59"},{"issue":"Suppl 1","key":"2021122308455024900_B60","doi-asserted-by":"crossref","first-page":"S699","DOI":"10.1007\/s12032-010-9757-z","article-title":"Sunitinib-induced severe hypothyroidism with cardiac compromise","volume":"28","author":"Collinson","year":"2011","journal-title":"Med Oncol"},{"key":"2021122308455024900_B61","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/annonc\/mdp025","article-title":"Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: A multicenter analysis","volume":"20","author":"Di Lorenzo","year":"2009","journal-title":"Ann Oncol"},{"key":"2021122308455024900_B62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jc.2006-0696","article-title":"Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects","volume":"92","author":"Golden","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B63","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1200\/JCO.2006.09.1215","article-title":"High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults &gt; or = 60 years old with relapsed or refractory B-cell lymphoma","volume":"25","author":"Gopal","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B64","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2006.05.8198","article-title":"Phase II trial of CHOP chemotherapy followed by tositumomab\/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group Protocol S9911","volume":"24","author":"Press","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122308455024900_B65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","article-title":"131I-tositumomab therapy as initial treatment for follicular lymphoma","volume":"352","author":"Kaminski","year":"2005","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1043-2760(00)00359-3","article-title":"Cranial irradiation and central hypothyroidism","volume":"12","author":"Rose","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2021122308455024900_B67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1011407910913","article-title":"Hypopituitarism following closed head injury","volume":"3","author":"Segal-Lieberman","year":"2000","journal-title":"Pituitary"},{"key":"2021122308455024900_B68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0889-8529(18)30262-7","article-title":"Endocrine complications of sarcoidosis","volume":"20","author":"Bell","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122308455024900_B69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000441-198305000-00002","article-title":"The endocrine manifestations of hemochromatosis","volume":"285","author":"McNeil","year":"1983","journal-title":"Am J Med Sci"},{"key":"2021122308455024900_B70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective ligands","volume":"340","author":"Sherman","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B71","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1515\/JPEM.2011.407","article-title":"Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia","volume":"24","author":"Baronio","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021122308455024900_B72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"key":"2021122308455024900_B73","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/thy.1998.8.703","article-title":"Thyroid hormone receptor coactivators and corepressors","volume":"8","author":"Koenig","year":"1998","journal-title":"Thyroid"},{"key":"2021122308455024900_B74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/thy.1996.6.497","article-title":"Nongenomic actions of thyroid hormone","volume":"6","author":"Davis","year":"1996","journal-title":"Thyroid"},{"key":"2021122308455024900_B75","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1525-1497.1997.07109.x","article-title":"Do traditional symptoms of hypothyroidism correlate with biochemical disease?","volume":"12","author":"Canaris","year":"1997","journal-title":"J Gen Intern Med"},{"key":"2021122308455024900_B76","first-page":"983","volume-title":"The Thyroid: A Fundamental and Clinical Text","author":"Foley","year":"2000","edition":"8th ed."},{"key":"2021122308455024900_B77","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0022-3476(78)80514-9","article-title":"Association of primary hypothyroidism and slipped capital femoral epiphysis","volume":"93","author":"Hirano","year":"1978","journal-title":"J Pediatr"},{"key":"2021122308455024900_B78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(74)80403-8","article-title":"Muscular hypertrophy in hypothyroid children: The Kocher-Debr\u00e9-Semelaigne syndrome. A review of 23 cases","volume":"85","author":"Najjar","year":"1974","journal-title":"J Pediatr"},{"key":"2021122308455024900_B79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-85-2-195","article-title":"Pituitary enlargement, pituitary failure, and primary hypothyroidism","volume":"85","author":"Vagenakis","year":"1976","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B80","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0022-3468(03)00403-2","article-title":"Polycystic ovaries, precocious puberty and acquired hypothyroidism: The Van Wyk and Grumbach syndrome","volume":"38","author":"Chattopadhyay","year":"2003","journal-title":"J Pediatr Surg"},{"key":"2021122308455024900_B81","first-page":"849","article-title":"Sexual maturation in juvenile hypothyroidism","volume":"48","author":"Barnes","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"2021122308455024900_B82","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-89-4-519","article-title":"Hypothermia: pathophysiology, clinical settings, and management","volume":"89","author":"Reuler","year":"1978","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B83","first-page":"950","article-title":"[So-called secondary or thyroid-resistant myxedema]","volume":"92","author":"Patrassi","year":"1950","journal-title":"Munch Med Wochenschr"},{"key":"2021122308455024900_B84","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1073\/pnas.89.12.5251","article-title":"Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism","volume":"89","author":"Ladenson","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122308455024900_B85","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/003693309403900309","article-title":"Hypothyroidism presenting with cardiac tamponade","volume":"39","author":"Quin","year":"1994","journal-title":"Scott Med J"},{"key":"2021122308455024900_B86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1536\/jhj.44.447","article-title":"Myxedema associated with cardiac tamponade","volume":"44","author":"Lin","year":"2003","journal-title":"Jpn Heart J"},{"key":"2021122308455024900_B87","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.98.5.1130","article-title":"Hypothyroidism and pleural effusions","volume":"98","author":"Gottehrer","year":"1990","journal-title":"Chest"},{"key":"2021122308455024900_B88","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archsurg.1966.01320240148033","article-title":"Paralytic ileus in myxedema","volume":"92","author":"Boruchow","year":"1966","journal-title":"Arch Surg"},{"key":"2021122308455024900_B89","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.8.7.511","article-title":"Neurologic manifestations of myxedema","volume":"8","author":"Nickel","year":"1958","journal-title":"Neurology"},{"key":"2021122308455024900_B90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.2.4627.555","article-title":"Myxoedematous madness","volume":"2","author":"Asher","year":"1949","journal-title":"BMJ"},{"key":"2021122308455024900_B91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196306000-00008","article-title":"Psychotic behavior as the initial indicator of adult myxedema","volume":"136","author":"Logothetis","year":"1963","journal-title":"J Nerv Ment Dis"},{"key":"2021122308455024900_B92","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.16.10.957","article-title":"Myxedema and ataxia. Cerebellar alterations and \u201cneural myxedema bodies.\u201d","volume":"16","author":"Price","year":"1966","journal-title":"Neurology"},{"key":"2021122308455024900_B93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/pgmj.53.615.46","article-title":"Myxoedema coma presenting in status epilepticus","volume":"53","author":"Woods","year":"1977","journal-title":"Postgrad Med J"},{"key":"2021122308455024900_B94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-8529(18)30166-X","article-title":"Myxedema coma. A form of decompensated hypothyroidism","volume":"22","author":"Nicoloff","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122308455024900_B95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0889-8529(05)70186-9","article-title":"Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease","volume":"30","author":"Ross","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122308455024900_B96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/42.1.140","article-title":"Current status and performance goals for serum thyrotropin (TSH) assays","volume":"42","author":"Spencer","year":"1996","journal-title":"Clin Chem"},{"key":"2021122308455024900_B97","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1210\/jc.2007-0287","article-title":"National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction","volume":"92","author":"Spencer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"2021122308455024900_B98","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2007-0141","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline","volume":"92","author":"Abalovich","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B99","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"2021122308455024900_B100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/jc.2009-1845","article-title":"Age- and race-based serum thyrotropin reference limits","volume":"95","author":"Surks","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B101","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1210\/jc.2005-0455","article-title":"The evidence for a narrower thyrotropin reference range is compelling","volume":"90","author":"Wartofsky","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B102","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1210\/jc.2005-0170","article-title":"The thyrotropin reference range should remain unchanged","volume":"90","author":"Surks","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B103","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/eje.1.02136","article-title":"Is there a need to redefine the upper normal limit of TSH?","volume":"154","author":"Brabant","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2021122308455024900_B104","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease","volume":"87","author":"Andersen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B105"},{"key":"2021122308455024900_B106","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM198703263161302","article-title":"Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans","volume":"316","author":"Fish","year":"1987","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B107","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1001\/jama.1989.03420180077034","article-title":"The aging thyroid. The use of thyroid hormone in older persons","volume":"261","author":"Sawin","year":"1989","journal-title":"JAMA"},{"key":"2021122308455024900_B108","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2011-1329","article-title":"Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine","volume":"96","author":"Celi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B109","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.2002.01654.x","article-title":"Psychological well-being in patients on \u2018adequate\u2019 doses of l-thyroxine: Results of a large, controlled community-based questionnaire study","volume":"57","author":"Saravanan","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122308455024900_B110","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1172\/JCI118353","article-title":"Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats","volume":"96","author":"Escobar-Morreale","year":"1995","journal-title":"J Clin Invest"},{"key":"2021122308455024900_B111","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/endo.137.6.8641203","article-title":"Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat","volume":"137","author":"Escobar-Morreale","year":"1996","journal-title":"Endocrinology"},{"key":"2021122308455024900_B112","doi-asserted-by":"crossref","first-page":"a801","DOI":"10.1136\/bmj.a801","article-title":"Management of hypothyroidism in adults","volume":"337","author":"Vaidya","year":"2008","journal-title":"BMJ"},{"key":"2021122308455024900_B113","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/er.2011-0011","article-title":"The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy","volume":"32","author":"Rivkees","year":"2011","journal-title":"Endocr Rev"},{"key":"2021122308455024900_B114","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.1998.8.737","article-title":"Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry","volume":"8","author":"Cooper","year":"1998","journal-title":"Thyroid"},{"key":"2021122308455024900_B115","first-page":"344","article-title":"Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer","volume":"75","author":"Burmeister","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B116","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4158\/EP.5.5.233","article-title":"Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism","volume":"5","author":"Gordon","year":"1999","journal-title":"Endocr Pract"},{"key":"2021122308455024900_B117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jc.2004-1306","article-title":"Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases","volume":"90","author":"Santini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B118","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1210\/jc.2007-0297","article-title":"Thyroid hormone replacement for central hypothyroidism: A randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine","volume":"92","author":"Slawik","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B119","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jamcollsurg.2012.12.002","article-title":"Using body mass index to predict optimal thyroid dosing after thyroidectomy","volume":"216","author":"Ojomo","year":"2013","journal-title":"J Am Coll Surg"},{"key":"2021122308455024900_B120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199902113400603","article-title":"Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism","volume":"340","author":"Bunevicius","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122308455024900_B121","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/jc.2006-0448","article-title":"Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: Meta-analysis of randomized controlled trials","volume":"91","author":"Grozinsky-Glasberg","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B122","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1210\/jcem.86.10.7961","article-title":"The treatment of subclinical hypothyroidism is seldom necessary","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B123","first-page":"2993","article-title":"Clinical review 115: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature","volume":"85","author":"Danese","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122308455024900_B124","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-137-11-200212030-00011","article-title":"Effects of subclinical thyroid dysfunction on the heart","volume":"137","author":"Biondi","year":"2002","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0002-9149(03)00322-9","article-title":"Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy","volume":"91","author":"Brenta","year":"2003","journal-title":"Am J Cardiol"},{"key":"2021122308455024900_B126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-101-1-18","article-title":"L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial","volume":"101","author":"Cooper","year":"1984","journal-title":"Ann Intern Med"},{"key":"2021122308455024900_B127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1988.tb00250.x","article-title":"A double-blind cross-over 12-month study of L-thyroxine treatment of women with \u2018subclinical\u2019 hypothyroidism","volume":"29","author":"Nystr\u00f6m","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122308455024900_B128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF02598988","article-title":"Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?","volume":"11","author":"Jaeschke","year":"1996","journal-title":"J Gen Intern Med"},{"key":"2021122308455024900_B129","first-page":"367","article-title":"Subclinical hypothyroidism: Neurobehavioral features and beneficial effect of L-thyroxine treatment","volume":"71","author":"Monzani","year":"1993","journal-title":"Clin Investig"},{"key":"2021122308455024900_B130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2013-0237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2013-0237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/1\/34\/41861253\/oncolo_19_1_34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/1\/34\/41861253\/oncolo_19_1_34.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T01:27:36Z","timestamp":1640309256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/1\/34\/6400001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,5]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,5]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2013-0237","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,1,1]]},"published":{"date-parts":[[2013,12,5]]}}}